Different types of ILD appear to be associated ... Raghu G, Remy-Jardin M, Richeldi L, et al. Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ...

Idiopathic pulmonary fibrosis (IPF) is characterized by a progressive decline in lung function, worsening quality of life, and high mortality. However, the rate and pattern of progression of IPF ...

An international study has identified two types of these so-called dysbioses ... Researchers Identify Protein Connected to Aging and Idiopathic Pulmonary Fibrosis July 25, 2022 — Idiopathic ...

A recent study showed that the COPD assessment test was reliable and responsive for assessing health status in fibrotic ...

Identifying the underlying causes of prolonged lung inflammation associated with radiographic abnormalities could be key understanding long COVID and other lung conditions, researchers say.

Pulmonary fibrosis, including its most common form, idiopathic pulmonary fibrosis ... including alveolar type 2 (AT2) cells, which are responsible for maintaining the lung's delicate architecture.

MannKind (MNKD) announced the successful completion of its first-in-human Phase 1 study of nintedanib DPI, or MNKD-201, for pulmonary fibrotic ...

The asset at play is fipaxalparant, a candidate designed to block the lysophosphatidic acid receptor 1 (LPAR1). Amgen tested ...

Met primary objective demonstrating nintedanib DPI was safe and well toleratedParticipants did not experience adverse events typically reported ...

its experimental therapy for serious lung disease idiopathic pulmonary fibrosis (IPF). The study will use the e-ILD platform to process high-resolution chest computed tomography (HRCT) images ...

MannKind completes phase 1 trial of nintedanib DPI for pulmonary fibrotic diseases: Danbury, Connecticut Tuesday, November 5, 2024, 16:00 Hrs [IST] MannKind Corporation, a company ...